GE HealthCare Technologies GEHC PDx — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's pdx — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's pdx — total revenues?
- GE HealthCare Technologies (GEHC) reported pdx — total revenues of $770M in Q1 2026.
- How has GE HealthCare Technologies's pdx — total revenues changed year-over-year?
- GE HealthCare Technologies's pdx — total revenues increased by 21.8% year-over-year, from $632M to $770M.
- What is the long-term trend for GE HealthCare Technologies's pdx — total revenues?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's pdx — total revenues has grown at a 9.5% compound annual growth rate (CAGR), from $2.02B to $2.9B.
- What does pdx — total revenues mean?
- Represents the total gross income generated by the Pharmaceutical Diagnostics segment through the sale of contrast media and molecular imaging agents. This metric reflects the market demand for the segment's specialized diagnostic products used in medical imaging procedures.